It's our mission at the Environmental Working Group to use the power of information to protect human health and the environment.
Often, that means building databases. EWG's data gives you practical solutions to protect yourself and your family from the health risks we all face from everyday exposures to myriad industrial chemicals.
In 2004 we launched Skin Deep, an online safety guide for cosmetics and personal care products. Our aim was to fill in where companies and the government leave off: companies are allowed to use almost any ingredient they wish, and our government doesn't require companies to test products for safety before they're sold. EWG's scientists built Skin Deep to be a one-of-a-kind resource, integrating our in-house collection of personal care product ingredient listings with more than 50 toxicity and regulatory databases.
Now in its fourth year and third major update, our Skin Deep database provides you with easy-to-navigate safety ratings for nearly a quarter of all products on the market — 52,182 products with 8,798 ingredients. At about one million page views per month, Skin Deep is the world's largest and most popular product safety guide.
And we don't stop with shopping tips. EWG is also working to fix the policies that allow our over-exposure to toxic chemicals. Sign our petition to Congress demanding product safety testing.
Read more:
About the Campaign for Safe Cosmetics
Quick facts on Skin Deep
Skin Deep Product and Ingredient Databases
Data sources - toxicity, regulatory, and study availability databases
Skin Deep's Dual Rating Factors
Skin Deep helps fuel the nationwide Campaign for Safe Cosmetics, a coalition of public health, educational, religious, labor, womens, environmental and consumer groups working to protect the health of consumers and workers by requiring the health and beauty industry to phase out the use of dangerous chemicals and replace them with safer alternatives. Through the Campaign, as of May 2007 over 500 companies have joined the effort by signing the Compact for Safe Cosmetics. Environmental Working Group is a founding partner of the Campaign.
Skin Deep contains information and online safety assessments for:
Below we describe the data sources and the methodology we use to construct Skin Deep's linked databases of ingredients, products, brands, companies, hazards, testing availability, and regulatory status.
Product and ingredient data collection. One of the core components of Skin Deep is an electronic product database that details ingredients in 52,182 products as of Nov 20, 2007. We obtained data for products from online retailers,from manufacturers who entered product information directly to the site (a tool we provide to companies who have signed the Compact for Safe Cosmetics), and, to a lesser extent, through other methods described below. In most cases label information includes company, brand, product name, ingredients, warnings, and directions for use.
Product type information. EWG's product database structure within Skin Deep comprises eight major product categories — skin care, makeup, hair care, nails, eye care, feminine hygiene, dental and oral hygiene, and fragrances. Within these eight major categories are more than 90 product sub-type categories (e.g., shampoo, toothpaste, deodorant). EWG assigns appropriate categories and sub-categories to each product entered into Skin Deep's database, or reviews the categories assigned by product manufacturers who enter their products through the Manufacturer's Page accessible by companies who sign the Compact for Safe Cosmetics.
Product use information. We also record information on how the product is typically used. This information is an integral component of product safety assessment ratings — many hazards or safety recommendations associated with particular chemicals are a function of use, applying, for instance, only for inhalation exposures or for products that are not rinsed off the skin after they are applied. We compile the following data for each product entered into the database, or review these data for products added by site users:
Product demographic information. For use in specialized displays of product information, we compile demographic information on the product's intended users, recording if the product is intended primarily for women or men, or if the product is marketed for use by people of color, teenagers, children (2 to 10), or infants (0 to 2).
Skin Deep currently contains information on nearly 151,163 unique personal care product ingredients, as culled from ingredient labels on 52,182 products and from the scientific and industry literature on personal care products. We assign a standardized name to each ingredient that we enter into the Skin Deep database, generally taken as the International Nomenclature for Cosmetic Ingredients (INCI) standard, with some exceptions where alternate names are more easily recognized by consumers. Each of these ingredient names is associated with a unique ingredient identification number in our database. The processing steps for ingredients are described below.
Obtaining product ingredient listings. EWG researchers built Skin Deep's ingredient database from the sources listed below; some ingredients are found in more than one of these sources. Each of these ingredients is contained in Skin Deep's ingredient database. Skin Deep users can navigate to a unique safety report for each of these ingredients via the site's search function or through site pages that provide data on companies, brands, and products.
EWG researchers constructed Skin Deep's ingredient database from the raw product data described above. First we parsed all the ingredient label data into the 146,162 unique ingredients and spellings that were listed on products labels. Then we correct misspellings in ingredient names, and combined ingredients that are synonyms of the same chemical into a single unique chemical assigned a unique chemical identifier in Skin Deep. The final ingredient database composites the 146,162 original chemical names into 8,798 unique chemical ingredients. (Through this work we see that companies routinely ignore FDA requirements for standard ingredient nomenclature, with each ingredient being shown an average of 17 different ways on the labels of the various products containing it.) Ingredients in Skin Deep come from the following sources:
Creating electronic ingredient lists from product labels. For product labels obtained from online retailers, we first process the ingredients with a parsing program that separates individual chemicals listed on the label. The automated parsing tools we have designed do not yet take into account every variance in labeling and will likely never be able to account for the wide range of errors in spacing and chemical delimiting we find on the ingredient labels we import into Skin Deep. Because of these factors, our programs do not perfect parse every ingredient, so we carefully review the result and manually correct ingredients that are not accurately parsed. These parsing steps are not necessary for new products the manufacturers enter via the product entry tool in the Skin Deep website, which requires ingredients to be entered one at a time.
Assigning unique chemical name and identification number to ingredients. We assign each ingredient a unique name and identification number within Skin Deep's ingredient database, in a multi-step process that often involves resolving chemical synonyms and names that are misspelled or that do not follow standard industry naming conventions:
Additional data stored with ingredient names. We also store in our ingredient database additional listed information about the ingredient — for instance, its status as an "active ingredient" in the product; its listing under "may contain," or "organic" under USDA standards; or its association with modifiers that indicate manufacturing methods, like USP for United States Pharmacopeia standards or NF for National Formulary standards.
Skin Deep currently holds products sold under 2,419 brand names and manufactured by 1,599 companies. To build this core brand and company database, we first estimated brand names as an extraction of the first words in product names, or relied on a listed brand name from product information originally extracted electronically, if available. We then manually corrected each estimated brand name, as needed, and associated each brand with a manufacturer. We did this primarily through online research of manufacturer websites and to a lesser extent through direct contact with manufacturers. We also linked manufacturers with parent companies, as appropriate, again primarily through online research. This brand and company database forms an integral part of the Skin Deep data structure.
Because animal testing is an issue of concern for many consumers, we also incorporate into Skin Deep information on company and brand stances on animal testing. Information on company positions on animal testing is obtained from People for the Ethical Treatment of Animals' (PETA) index. Brands are noted for their stance on animal testing based on a review of official statements provided by their parent companies to PETA. We will periodically update our Skin Deep database according to changes in PETA's roster.
EWG created a core database of chemical hazards, regulatory status, and study availability by pooling the data of more than 50 databases and sources from government agencies, industry panels, academic institutions, or other credible bodies. Collectively, these data sources detail more than 1,534 unique chemical classifications. These data comprise the keystone of the hazard and data gap assessments that are integral to Skin Deep, which build on a pairing of this toxicity, regulatory, and study availability database with EWG's ingredient database. Individual toxicity, regulatory, and study availability data sources we compiled are listed below.
Primary references - Known and probable carcinogens, reproductive and developmental toxicants
Secondary references - Known and probable carcinogens, reproductive and developmental toxicants
Other health endpoints (neurotoxicity, immunotoxicity, etc.)
Restrictions and warnings on safe use of ingredients in cosmetics
Persistent Bioaccumulative Toxics
Other resources relevant to consideration of human health risks
Availability of safety data
Human exposure factors
Study/assessment availability sources
Chemical nomenclature databases
We cross-linked the chemical names in our ingredient database with the names contained within our toxicity, regulatory, and study availability databases. These pairs form the basis for the hazard assessment ratings and data gap ratings that are an integral part of Skin Deep.
For an initial estimate of the chemical pairings between these two databases, we linked together chemicals when names matched perfectly between data sources; when Chemical Abstract Service (CAS) numbers matched, when they were available from our in-house CAS database; or when strings of letters matched between ingredients.
This initial process created over 189,999 initial name pairings, which we reviewed manually. We "unlinked" pairs when we found that the corresponding ingredient names were not, in fact, the same chemical. For many pairings we conducted a detailed review of the validity of the match between an ingredient and a hazard category, storing data on hazards that apply only to a particular route of exposure, for instance, for use in the hazard scores we developed for ingredients.
Introduction. Skin Deep relies on a dual rating system to inform consumers about product safety:
Database processing for dual rating system. Both of Skin Deep's rating factors (hazards and data gaps) are calculated from information drawn from the more than 50 integrated toxicity, regulatory, and study availability databases. To construct Skin Deep's rating factors, we divided the toxicity and regulatory databases in Skin Deep into their component pieces, each of which has a specific relevance to one of the two major rating factors. We divided the databases into 259 individual categories ranging from "known human carcinogen according to EPA" to "skin irritant identified by the Cosmetic Ingredient Review panel." We then mapped each of these categories into one of 205 "score categories" that are detailed in the table below. We ranked each score category according to a subjective assessment of its relative importance to public health or regulatory compliance, and then assigned a weight to each score category, also described in tables below.
The hazard score on Skin Deep is calculated in pieces.
Major categories of concern and their weighting factors. We categorized every piece of toxicity and hazard information in our integrated database into one of 19 different major categories. We developed these categories based on our review of available data, and modeled them after a variety of toxicity classification systems developed by government, industry, and academic organizations. We assigned to each of these categories a weighting factor representing a judgment on their relative importance to and impact on human health. We assigned higher weighting factors to categories of health concern for which studies provide evidence for effects at low doses, for permanent effects stemming from exposures during development, for toxicity endpoints that tend to impact multiple biological systems in the body or to impair reproduction. These endpoints include cancer, reproductive and development effects, immunotoxicity, neurotoxicity, and effects stemming from exposures to endocrine (hormone) disruptors. Organ systems that are more localized, such as gastrointestinal, kidney, respiratory, etc. are weighted in the mid-range. Toxic endpoints that measure adverse effects at the cellular level, which may or may not have implications for human health (such as mutations or biochemical changes) are weighted the least. This scoring system does not account for individual sensitivities or differences between the severities of different health endpoints within a particular category.
| Category | Weighting factor | Description |
| Cancer | 1.0 | linked to cancer in government, industry, or academic studies or assessments. |
| Developmental/reproductive toxicity | 1.0 | linked to developmental and reproductive toxicity, a broad class of health effects that can range from infertility and reproductive organ cancers to birth defects and developmental delays for children. |
| Neurotoxicity | 1.0 | linked to neurotoxicity, or harm to the brain and nervous system, a class of health problems that can range from subtle developmental delays to chronic nerve degeneration diseases. |
| Endocrine disruption | 1.0 | the body's natural hormones, the chemicals that carry messages across the body to manage growth, tissue repair, and reproduction. |
| Allergies/immunotoxicity | 1.0 | linked to immunotoxicity, or harm to the immune system, a class of health problems that manifest as allergic reactions or an impaired capacity to fight disease and repair damaged tissues in the body. |
| Miscellaneous | 1.0 | Includes toxicity endpoints that didn't fit in another category, efficacy scores (scores that might counteract toxicity scores), and scores for unidentified ingredients. |
| Violations, restrictions & warnings | 0.9 | prohibited for use in cosmetics, or subject to concentration, use, or manufacturing method restrictions, according to industry safety guidelines and government requirements and guidance from the U.S., E.U., Japan, and Canada. |
| Organ system toxicity (non-reproductive) | 0.5 | linked to toxicity of one or more biological systems in the body (cardiovascular, stomach and digestive trace, respiratory system, etc.) through laboratory studies or studies of people. |
| Persistence and bioaccumulation | 0.3 | persistent and/or bioaccumulative, resisting normal chemical breakdown in the environment; building up in wildlife, the food chain, and people; and lingering in body tissues for years or even decades after exposure. |
| Multiple, additive exposure sources | 0.3 | also found as contaminants in tap water and food, as ingredients in other kinds of consumer products, or in people in biomonitoring studies that measure chemicals in blood, urine, and other fluids and tissues. |
| Mutations | 0.3 | linked to both cancer and developmental defects. Includes government, industry, or academic assays, studies and assessments. |
| Biochemical or cellular level changes | 0.3 | the ability to affect the body at a cellular or biochemical level that may have larger, but poorly understood health implications. |
| Ecotoxicology | 0.2 | linked to toxicity of wildlife that may include fish, wildlife, plants, or other wild organisms. |
| Occupational hazards | 0.2 | linked to hazards for workers exposed on the job, including acute dangers from chemical handling, or longer term health effects from routine occupational exposures. |
| Irritation (skin, eyes, or lungs) | 0.1 | linked to irritation of the skin, eyes, or lungs according to government assessments, industry reviews, and peer-reviewed studies. |
We assigned numeric hazard scores for each scoring category based on judgment of the relative importance of each with respect to potential health concerns. These scores were informed by a number of factors, including the weight of the evidence associated with each scoring category (e.g. whether the chemical categorization derived from a full government assessment or from a single peer-reviewed study), and by other hazard classification systems, such as the Nordic Substances Substances Database.
For most types of hazards, we assign scores as a function of the lowest known harmful dose where that information is available, the weight of the evidence (limited, moderate, and strong evidence), and the source of the data (individual study; literature review, industry review panel, or major government study; and comprehensive government assessment). We use the scores shown below in our calculations of final hazard (concern) scores for ingredients and products, as described in subsequent sections. The tables below detail the hazard scoring system.
The scores we assign for these hazard categories range from a maximum of 100 for chemicals known to be toxic to humans in a given category as determined by a definitive government assessment, to 20 for chemicals showing limited evidence for toxicity in a non-academic review, down to 0 for chemicals determined not likely to be human toxicants.
| Hazard score category | Data source | Hazard Score |
| Known human toxicant | Government assessment | 100 |
| Possible human toxicant | Government assessment | 55 |
| Limited evidence of human toxicity | Government assessment | 30 |
| Strong evidence for human toxicity | Literature review, industrial panel, or major government study | 55 |
| Moderate evidence for human toxicity | Literature review, industrial panel, or major government study | 30 |
| Limited evidence for human toxicity | Literature review, industrial panel, or major government study | 20 |
| One or more animal studies show effects at very low doses | Individual scientific or peer-reviewed study | 30 |
| One or more animal studies show effects at low doses | Individual scientific or peer-reviewed study | 20 |
| One or more animal studies show effects at moderate doses | Individual scientific or peer-reviewed study | 10 |
| One or more animal studies show effects at high doses | Individual scientific or peer-reviewed study | 5 |
| Not likely to be a human toxicant | Government assessment, literature review, industrial panel, or major government study | 0 |
We assign scores for mutation data essentially the same as for other hazard classifications (as in Table 2), but make modifications to account for the unique range of tests available to define mutation, as shown in this table. Scores we assign for mutation range from 100 for a known mutagen as determined by a definitive government assessment, to 10 for ingredients for which one or more studies on micro-organisms show positive mutation results to 0 for ingredients determined not likely to be mutagens in humans based on a definitive government review.
| Hazard score category | Data source | Hazard Score |
| Known mutagen | Government assessment | 100 |
| Possible mutagen | Government assessment | 55 |
| Strong evidence for mutagenity in human cells | Literature review, industrial panel, or major government study | 55 |
| Moderate evidence for mutagenity in human cells | Literature review, industrial panel, or major government study | 30 |
| Limited evidence of mutagenity in human cells | Government assessment | 30 |
| One or more studies on mammalian cells show positive mutation results | Individual scientific or peer-reviewed study | 30 |
| Limited evidence of mutagenity in human cells | Literature review, industrial panel, or major government study | 20 |
| One or more studies on non-mammalian cells show positive mutation results | Individual scientific or peer-reviewed study | 20 |
| One or more studies on micro-organisms show positive mutation results | Individual scientific or peer-reviewed study | 10 |
| Not likely to be a mutagen | Government assessment, literature review, industrial panel, or major government study | 0 |
We assign scores for biochemical and celluar level changes where the human health impact may be unclear. The framework is essentially the same as for other hazard classifications (as in Table 2) with some modifications to account for the unique range of tests available to define biochemical changes and because more significant reviews generally are undertaken only on concrete human health effects. Scores we assign for biochemical and cellular level changes range from 100 for a reactive oxygen species that are beginning to be linked up to definitive health effecdts to 5 for ingredients for high dose studies showing biochemical changes.
| Hazard score category | Data source | Hazard Score |
| Produces excess reactive oxygen species that can interfere with cellular signaling, cause mutations, lead to cell death and may be implicated in cardiovascular disease. | Individual scientific or peer-reviewed study | 100 |
| Interferes with gene expresion | Individual scientific or peer-reviewed study | 30 |
| One or more animal studies show effects at very low doses where the human health implications are not yet well understood | Individual scientific or peer-reviewed study | 30 |
| One or more animal studies show effects at low doses where the human health implications are not yet well understood | Individual scientific or peer-reviewed study | 20 |
| One or more animal studies show effects at moderate doses where the human health implications are not yet well understood | Individual scientific or peer-reviewed study | 10 |
| One or more animal studies show effects at high doses where the human health implications are not yet well understood | Individual scientific or peer-reviewed study | 5 |
New to the third update of Skin Deep (May 2007) is a scoring framework to account for detailed toxicity study findings we have folded into Skin Deep from the variety of databases available to us, and over 6000 peer reviewed references.
We assign hazard scores to each recorded lowest toxic dose according to weighting factors used in the Nordic Substances Database classification system, as shown in Table 5. No attempt was made to evaluate the length of time or dosing regimen (such as differentiating between chronic and sub-chronic studies) for repeat doses or accounting for route of exposure. In cases of acute studies where the LOEL instead of the LD50 was reported, the doses were multiplied by a factor of 10.
| Potency | Acute Studies1 (LD50 — mg/kg of body mass) | Repeat Dose Studies2 (LOAEL — mg/kg day of body mass) |
| Very highly toxic — very low dose | <25 | <2.5 |
| Highly toxic — low dose | 25≤Dose<200 | 2.5≤Dose<20 |
| Moderately toxic — moderate dose | 200≤Dose<2000 | 20≤Dose<200 |
| Low toxicity - high dose | Dose≥2000 | Dose≥200 |
1. LD50 refers to the chemical dose at which 50% of the animals died.
2. LOAEL is the Lowest Observed Adverse Effect Level which is the lowest dose of a chemical at which a harmful effect is observed in a lab animal.
| Potency | Occupational 8 hr TLVs and PELs (mg/m3) |
| Very highly toxic — very low dose | <3.47 |
| Highly toxic - low dose | 3.47≤Dose<27.9 |
| Moderately toxic - moderate dose | 27.9≤Dose<279 |
| Low toxicity — High dose | ≥279 |
Note: We derived the occupations exposure factors shown above by converting the animal study doses define potency in the Nordict Substances Database (see Table 6) into equivalent concentrations in workplace air assuming a 70 kg male, 15 breathes/minute, 0.7 liters/breathe over an 8-hour workday.
Scores in this category range from a maximum of 100 for a violation of a ban to 1 for caustic chemicals used as a pH balancer in a specific product.
| Finding | Data source | Hazard Score |
| Banned or found unsafe for use in cosmetics | Government assessment | 100 |
| Violations of restrictions and safety warnings | Government assessment | 90 |
| Not safe in cosmetics for specific use | Literature review, industrial panel, or major government study | 40 |
| Safe use with an industry determined concentration limit | Literature review, industrial panel, or major government study | 25 |
| Safe use with specific consumer instructions | Literature review, industrial panel, or major government study | 10 |
| Safe use as a pH adjuster | Literature review, industrial panel, or major government study | 1 |
| Approved for use | Government assessment, literature review, industrial panel, or major government study | 0 |
Because many chemicals are found to persist in the environment and bioaccumulate in organisms and people, chemicals in this category are potentially harmful to both humans and people. Because so many different lists abound, we restrict scores to designations where an authoritative body has found the chemical to be hazardous to humans and where it suspects it might be hazardous to humans or wildlife.
For the hazard score category titled "Ingredients not fully identified," we assign a score of 100, flagging ingredients with unknown identity, such as fragrance and unidentified essential oils.
| Finding | Level of finding | Hazard Score |
| Persistent, bioaccumulative in wildlife and humans | Government assessment | 100 |
| Persistent, bioaccumulative in wildlife | Government assessment | 50 |
| Finding | Level of finding | Hazard Score |
| Used in food or as an additive with limited or no toxicity information available | Government assessment | 100 |
| Contaminant in tap water | Government assessment | 100 |
| In other consumer products besides personal care products | Government assessment | 50 |
| High production volume chemical | Government assessment | 50 |
| Environmental releases by industry | Government assessment | 50 |
| Used as an inert ingredient in pesticides | Government assessment | 50 |
| Designated as safe for use in food | Government assessment | 0 |
In the penultimate step for deriving product and ingredient hazard scores, we adjust preliminary scores to account for increased potential for an ingredient to penetrate the skin. Currently, we take into account the potential enhanced absorption of a product stemming from the presence of penetration enhancers, and known or potential nano-scale ingredients.
For nano-scale and potentially nano-scale ingredients, the ingredient scores are scaled as in Equation 3 with scaling factors of 1.5 and 1.25, respectively. The overall product scores are not adjusted. In cases where the skin absorption potential is lowered, we also scale downwards for the individual ingredients. Scores are multiplied for 0.5 for reduced or limited absorption, and 0.25 where the ingredient has been shown not to absorb into intact skin. Only for ingredients shown not to absorb into intact, damaged, infant, and thinner skin, is the factor reduced to 0.
New to the May 2007 release of Skin Deep is a data gap rating that gives site users a measure on the availability of safety data for any particular ingredient or product. A hazard rating of "low concern" (shown as a green circle in Skin Deep) might be rated in that category because of definitive data proving its safety, or because of a near absence of any safety studies that would illuminate hazards. The data gap rating helps site users know the difference, and to buy products with low hazard concerns backed up by safety data, if they choose. The data gap score was derived from the data availability factors detailed below.
Different sources are more or less thorough in terms of acquiring or evaluating data. A scientific study uses and weighs the available data based on the listed authors knowledge and experience. In contrast, government assessment panels are comprised of multiple experts and must conduct an expansive literature review.
| Data source (weight of evidence) | Data availability factor |
| Innocuous | 100 |
| Government assessment | 80 |
| Literature review, industrial panel, or major government study | 60 |
| Individual scientific or peer-reviewed study | 30 |
For assessments and reviews, the panel or reviwer usually expresss the findings based on the weight of evidence. Not only do these different findings have different implications for regulations, they inherently imply the certainty of the experts in their overall finding. Known assessments express no doubt, while possible toxicants or weak evidence express greater doubt.
| Finding | Certainty of finding |
| Known toxicant | 100 |
| Probable toxicant or strong evidence | 75 |
| Possible toxicant or moderate evidence | 50 |
| Limited evidence | 25 |
| Unassessed or unknown | 0 |
In the case of data drawn from individual studies in the peer reviewed literature, rather than attempting to weight the uncertainty inherent in the study itself, the conclusions of such studies are assigned a constant certainty factor of 30% to represent the fact that they do not carry the same weight as a full-blown government assessment of hazard.
We excluded data on violations and data on other sources of human exposure from the uncertainty metric, because these are not measures of toxicity. We also counted and considered the number of studies that are available in PubMed for each ingredient by an automated querying system that looked for synonyms or, where available, the CAS registry number along with studies focusing on toxicity (such as but not limited to cancer, sensitization, liver toxicity, dermal penetration, etc. We hypothesized that greater numbers of studies in Pubmed for a particular ingredient was likely to increase the odds that government and industry toxicity and regulatory databases accurately reflects information on the ingredient's toxicity. The Pubmed category contributed 10% to the overall uncertainty and was scored as described in Table 12.
| Number of studies available for a particular ingredient | Certainty factor |
| 0 | 0 |
| >0 and <10 | 1 |
| ≥10 and <25 | 2 |
| ≥25 and <50 | 3 |
| ≥50 and <100 | 5 |
| ≥100 and <250 | 8 |
| ≥250 and <1000 | 9 |
| ≥ 1000 | 10 |
Finally, where government, industry, or an academic identified data gaps in their reviews, we reduced the certainty of all reviews and assessments for that ingredient by 50%.
At the ingredient level, uncertainty was determined by:

where Ccategory is the certainty associated with a particular score category and w is the weight of the category. We chose to square certainty, rather than uncertainty to reduce uncertainty in cases where the hazards of a product are known.
At the product level,

where n is the number of ingredients and Un is the uncertainty associated with a particular ingredient.
No items in basket.
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
Stay informed with email updates on toxics in everyday products and how they can affect your health.
'I just wanted to let you know how much Skin Deep has changed my daughter's (and my) life.'
—Melissa M., Michigan